Review: Pathogenesis of cholestatic liver diseases

World J Hepatol. 2020 Aug 27;12(8):423-435. doi: 10.4254/wjh.v12.i8.423.

Abstract

Cholestatic liver diseases (CLD) begin to develop after an impairment of bile flow start to affect the biliary tree. Cholangiocytes actively participate in the liver response to injury and repair and the intensity of this reaction is a determinant factor for the development of CLD. Progressive cholangiopathies may ultimately lead to end-stage liver disease requiring at the end orthotopic liver transplantation. This narrative review will discuss cholangiocyte biology and pathogenesis mechanisms involved in four intrahepatic CLD: Primary biliary cholangitis, primary sclerosing cholangitis, cystic fibrosis involving the liver, and polycystic liver disease.

Keywords: Bile acid; Cholangitis; Cholestasis; Epigenomics; Immunogenetics; Pathogenesis.

Publication types

  • Review